Different accumulation of temocapril and enalapril during repeated dosing in elderly patients

被引：1
|
作者：
Arakawa, M
Ohmori, M
Harada, K
Araki, N
Saitoh, T
Fujimura, A [1 ]
机构：
[1] Jichi Med Sch, Dept Clin Pharmacol, Minami Kawachi, Tochigi 32904, Japan
[2] Moka Hosp, Tochigi 3290498, Japan
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2005年 / 59卷 / 04期
关键词：
D O I：
10.1111/j.1365-2125.2005.02346.x
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：489 / 490
页数：2
相关论文
共 50 条
  • [1] Pharmacokinetic and pharmacodynamic alterations of enalapril and temocapril during a repeated dosing in elderly hypertensive patients
    Arakawa, M
    Ohmori, M
    Harada, K
    Araki, N
    Saitoh, T
    Sugimoto, K
    Fujimura, A
    JOURNAL OF HYPERTENSION, 2002, 20 : S342 - S342
  • [2] Pharmacokinetic and pharmacodynamic changes of enalapril and temocapril during a repeated dosing in elderly hypertensive patients.
    Ohmori, M
    Arakawa, M
    Harada, K
    Araki, N
    Kawaguchi, A
    Sugimoto, K
    Saito, T
    Fujimura, A
    JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 43 (09): : 1033 - 1033
  • [3] Pharmacokinetic and pharmacodynamic alterations of enalapril and temocapril during repeated dosing in elderly hypertensive patients.
    Arakawa, M
    Ohmori, M
    Harada, K
    Araki, N
    Saito, T
    Sugimoto, K
    Fujimura, A
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (02) : P69 - P69
  • [4] Pharmacokinetics and pharmacodynamics of temocapril during repeated dosing in elderly hypertensive patients
    Masashi Arakawa
    Masato Sasaki
    Masami Ohmori
    Kazuhiro Harada
    Akio Fujimura
    European Journal of Clinical Pharmacology, 2001, 56 : 775 - 779
  • [5] Pharmacokinetics and pharmacodynamics of temocapril during repeated dosing in elderly hypertensive patients
    Arakawa, M
    Sasaki, M
    Ohmori, M
    Harada, K
    Fujimura, A
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 56 (11) : 775 - 779
  • [6] Pharmacokinetics and pharmacodynamics of temocapril during a repeated dosing in elderly hypertensive patients
    Arakawa, M
    Sasaki, M
    Ohmori, M
    Harada, K
    Fujimura, A
    JOURNAL OF HYPERTENSION, 2000, 18 : S49 - S49
  • [7] CLEARANCE OF TEMOCAPRIL AND ENALAPRIL DURING HEMODIALYSIS-TREATMENT
    KODA, Y
    SAITO, H
    SASAHARA, K
    HIRASAWA, Y
    CLINICAL DRUG INVESTIGATION, 1995, 9 (04) : 232 - 238
  • [8] EFFECT OF AGE ON RESPONSE TO REPEATED ORAL DOSING WITH ENALAPRIL
    LEES, KR
    HOCKINGS, N
    REID, JL
    ACTA PHARMACOLOGICA ET TOXICOLOGICA, 1986, 59 : 104 - 104
  • [9] DOSING REGIMENS OF CAPTOPRIL AND ENALAPRIL IN ELDERLY PATIENTS AND THOSE WITH RENAL-INSUFFICIENCY
    BEGG, EJ
    NEW ZEALAND MEDICAL JOURNAL, 1987, 100 (835) : 695 - 695
  • [10] PHARMACOKINETICS OF TEMOCAPRIL AND ENALAPRIL IN PATIENTS WITH VARIOUS DEGREES OF RENAL-INSUFFICIENCY
    OGUCHI, H
    MIYASAKA, M
    KOIWAI, T
    TOKUNAGA, S
    HORA, K
    SATO, K
    YOSHIE, T
    SHIOYA, H
    FURUTA, S
    CLINICAL PHARMACOKINETICS, 1993, 24 (05) : 421 - 427
12345